IFN-γ Regulation in Anti-CD4 Antibody-Induced T Cell Unresponsiveness

Journal of the American Society of Nephrology

Volumn 15, Issue 3, 2004, Pages 695-703

  Sawitzki, Birgit ^a   Kieselbach, Brit ^a   Fisser, Marion ^a   Meisel, Christian ^a   Vogt, Katrin ^a   Gaestel, Matthias ^b   Lehmann, Manfred ^c   Risch, Kirsten ^c   Grütz, Gerald ^a   Volk, Hans Dieter ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INITIATION FACTOR 2; INTERLEUKIN 15; INTERLEUKIN 2; MESSENGER RNA; OKT 4; PHOSPHATIDYLINOSITOL 3 KINASE; RAPAMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEPHOSPHORYLATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOHISTOLOGY; IMMUNOLOGICAL TOLERANCE; KIDNEY ALLOGRAFT; MIXED LYMPHOCYTE REACTION; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

EID: 10744230932     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000115523.50962.C0     Document Type: Article

References (36)

1. Goronzy J, Weyand CM, Fathman CG: Long-term humoral unresponsiveness in vivo, induced by treatment with monoclonal antibody against L3T4. J Exp Med 164: 911-925, 1986
2. Saitovitch D, Bushell A, Mabbs DW, Morris PJ, Wood KJ: Kinetics of induction of transplantation tolerance with a nondepleting anti-Cd4 monoclonal antibody and donor-specific transfusion before transplantation. A critical period of time is required for development of immunological unresponsiveness. Transplantation 61: 1642-1647, 1996
3. Chen ZK, Cobbold SP, Waldmann H, Metcalfe S: Amplification of natural regulatory immune mechanisms for transplantation tolerance. Transplantation 62: 1200-1206, 1996
4. Onodera K, Volk HD, Ritter T, Kupiec-Weglinski JW: Thymus requirement and antigen dependency in the "infectious" tolerance pathway in transplant recipients. J Immunol 160: 5765-5772, 1998
5. Qin S, Cobbold SP, Pope H, Elliott J, Kioussis D, Davies J, Waldmann H: "Infectious" transplantation tolerance. Science 259: 974-977, 1993
6. Onodera K, Hancock WW, Graser E, Lehmann M, Sayegh MH, Strom TB, Volk HD, Kupiec-Weglinski JW: Type 2 helper T cell-type cytokines and the development of "infectious" tolerance in rat cardiac allograft recipients. J Immunol 158: 1572-1581, 1997
7. Siegling A, Lehmann M, Riedel H, Platzer C, Brock J, Emmrich F, Volk HD: A nondepleting anti-rat CD4 monoclonal antibody that suppresses T helper 1-like but not T helper 2-like intragraft lymphokine secretion induces long-term survival of renal allografts. Transplantation 57: 464-467, 1994
8. Lehmann M, Graser E, Risch K, Hancock WW, Muller A, Kuttler B, Hahn HJ, Kupiec-Weglinski JW, Brock J, Volk HD: Anti-CD4 monoclonal antibody-induced allograft tolerance in rats despite persistence of donor-reactive T cells. Transplantation 64: 1181-1187, 1997
9. Fehervari Z, Cooke A, Brett S, Turner J: Perturbation of naive TCR transgenic T cell functional responses and upstream activation events by anti-CD4 monoclonal antibodies. Eur J Immunol 32: 333-340, 2002
10. Harding S, Lipp P, Alexander DR: A therapeutic CD4 monoclonal antibody inhibits TCR-zeta chain phosphorylation, zeta-associated protein of 70-kDa Tyr319 phosphorylation, and TCR internalization in primary human T cells. J Immunol 169: 230-238, 2002
11. Portoles P, de Ojeda G, Criado G, Fernandez-Centeno E, Rojo JM: Antibody-induced CD3-CD4 coligation inhibits TCR/CD3 activation in the absence of costimulatory signals in normal mouse CD4(+) T lymphocytes. Cell Immunol 195: 96-109, 1999
12. Chirmule N, Avots A, LakshmiTamma SM, Pahwa S, Serfling E: CD4-mediated signals induce T cell dysfunction in vivo. J Immunol 163: 644-649, 1999
13. Sawitzki B, Lehmann M, Vogt K, Risch K, Brock J, Kupiec-Weglinski JW, Volk HD: Bag-1 up-regulation in anti-CD4 mAb treated allo-activated T cells confers resistance to apoptosis. Eur J Immunol 32: 800-809, 2002
14. Moon JJ, Nelson BH: Phosphatidylinositol 3-kinase potentiates, but does not trigger, T cell proliferation mediated by the IL-2 receptor. J Immunol 167: 2714-2723, 2001
15. Hodge DL, Martinez A, Julias JG, Taylor LS, Young HA: Regulation of nuclear gamma interferon gene expression by interleukin 12 (IL-12) and IL-2 represents a novel form of posttranscriptional control. Mol Cell Biol 22: 1742-1753, 2002
16. Yu TK, Caudell EG, Smid C, Grimm EA: IL-2 activation of NK cells: Involvement of MKK1/2/ERK but not p38 kinase pathway. J Immunol 164: 6244-6251, 2000
17. Gollob JA, Schnipper CP, Murphy EA, Ritz J, Frank DA: The functional synergy between IL-12 and IL-2 involves p38 mitogen-activated protein kinase and is associated with the augmentation of STAT serine phosphorylation. J Immunol 162: 4472-4481, 1999
18. Malek TR, Yu A, Scibelli P, Lichtenheld MG, Codias EK: Broad programming by IL-2 receptor signaling for extended growth to multiple cytokines and functional maturation of antigen-activated T cells. J Immunol 166: 1675-1683, 2001
19. Collart MA, Belin D, Vassalli JD, de Kossodo S, Vassalli P: Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors. J Exp Med 164: 2113-2118, 1986
20. Ucla C, Roux-Lombard P, Fey S, Dayer JM, Mach B: Interferon gamma drastically modifies the regulation of interleukin 1 genes by endotoxin in U937 cells. J Clin Invest 85: 185-191, 1990
21. Nagano H, Mitchell RN, Taylor MK, Hasegawa S, Tilney NL, Libby P: Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. J Clin Invest 100: 550-557, 1997
22. Binder J, Graser E, Hancock WW, Wasowska B, Sayegh MH, Volk HD, Kupiec-Weglinski JW: Downregulation of intragraft IFN-gamma expression correlates with increased IgG1 alloantibody response following intrathymic immunomodulation of sensitized rat recipients. Transplantation 60: 1516-1524, 1995
23. Zou W, Borvak J, Marches F, Wei S, Galanaud P, Emilie D, Curiel TJ: Macrophage-derived dendritic cells have strong Th1-polarizing potential mediated by beta-chemokines rather than IL-12. J Immunol 165: 4388-4396, 2000
24. Lehmann M, Risch K, Nizze H, Brandenburg G, Ritter T, Brock J, Volk HD: Abolition of anti-CD4-induced allotransplantation tolerance by exogenous IL-2. Transplant Proc 31: 1220-1221, 1999
25. Garcia-Sanz JA, Mikulits W, Livingstone A, Lefkovits I, Mullner EW: Translational control: A general mechanism for gene regulation during T cell activation. FASEB J 12: 299-306, 1998
26. Welsh GI, Miyamoto S, Price NT, Safer B, Proud CG: T-cell activation leads to rapid stimulation of translation initiation factor eIF2B and inactivation of glycogen synthase kinase-3. J Biol Chem 271: 11410-11413, 1996
27. Kaufman RJ: Double-stranded RNA-activated protein kinase mediates virus-induced apoptosis: A new role for an old actor. Proc Natl Acad Sci U S A 96: 11693-11695, 1999
28. Munoz F, Martin ME, Manso-Tomico J, Berlanga J, Salinas M, Fando JL: Ischemia-induced phosphorylation of initiation factor 2 in differentiated PC12 cells: Role for initiation factor 2 phosphatase. J Neurochem 75: 2335-2345, 2000
29. Stumbles P, Mason D: Activation of CD4+ T cells in the presence of a nondepleting monoclonal antibody to CD4 induces a Th2-type response in vitro. J Exp Med 182: 5-13, 1995
30. Waldmann TA, Dubois S, Tagaya Y: Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: Implications for immunotherapy. Immunity 14: 105-110, 2001
31. Marks-Konczalik J, Dubois S, Losi JM, Sabzevari H, Yamada N, Feigenbaum L, Waldmann TA, Tagaya Y: IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice. Proc Natl Acad Sci U S A 97: 11445-11450, 2000
32. Li XC, Demirci G, Ferrari-Lacraz S, Groves C, Coyle A, Malek TR, Strom TB: IL-15 and IL-2: A matter of life and death for T cells in vivo. Nat Med 7: 114-118, 2001
33. Ellery JM, Nicholls PJ: Possible mechanism for the alpha subunit of the interleukin-2 receptor (CD25) to influence interleukin-2 receptor signal transduction. Immunol Cell Biol 80: 351-357, 2002
34. Sasaki T, Irie-Sasaki J, Jones RG, Oliveira-dos-Santos AJ, Stanford WL, Bolon B, Wakeham A, Itie A, Bouchard D, Kozieradzki I, Joza N, Mak TW, Ohashi PS, Suzuki A, Penninger JM: Function of PI3Kγ in thymocyte development, T cell activation, and neutrophil migration. Science 287: 1040-1046, 2000
35. Lafont V, Astoul E, Laurence A, Liautard J, Cantrell D: The T cell antigen receptor activates phosphatidylinositol 3-kinase-regulated serine kinases protein kinase B and ribosomal S6 kinase 1. FEBS Lett 486: 38-42, 2000
36. Ben-Asouli Y, Banai Y, Pel-Or Y, Shir A, Kaempfer R: Human interferon-gamma mRNA autoregulates its translation through a pseudoknot that activates the interferon-inducible protein kinase PKR. Cell 108: 221-232, 2002